New Brand, Same MS Drug: Novartis Launches Extavia In Europe
This article was originally published in The Pink Sheet Daily
Executive Summary
Novartis lays foundation for potential MS platform with European launch of its own branded version of Bayer-Schering’s Betaferon (interferon beta-1b).